Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27

Baseline patient and tumor characteristics differentially affected type of death in the MA.17 placebo-controlled letrozole trial where cardiovascular death was not separately identified. The MA.27 trial allowed competing risks analysis of breast cancer (BC), cardiovascular, and other type (OT) of de...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Breast Cancer Res Treat
Main Authors: Chapman, Judith-Anne W., Shepherd, Lois E., Ingle, James N., Muss, Hyman B., Pritchard, Kathleen I., Gelmon, Karen A., Whelan, Timothy J., Elliott, Catherine, Goss, Paul E.
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363272/
https://ncbi.nlm.nih.gov/pubmed/27006189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3761-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker